Order number | Author, year | Age (year) | Gender | Sings and symptoms | Pubertal development status | Imaging examination | Laboratory examination | Treatment | Treatment effect |
---|---|---|---|---|---|---|---|---|---|
1 | Farley, 1998 15 | 12 | Male | Fear of cold, mild anemia, pale and dry skin, visible carrot color | Height: 120.4 cm, Bone age delay, Prepubertal state | CT: the pituitary gland was enlarged and extended to the saddle Other: Perimetry suggested a superior visual field defect | FT4↓, TSH↑, TGAb+, TMAb+, PRL↑, GH↓, FSH↓ | Oral levothyroxine | After 6 weeks, the pituitary size returned to normal;FT4 returned to normal, TSH was close to normal; upper visual field defect improved and clinical symptoms were significantly relieved |
2 | Bhansali, 2004 5 | 13 | Female | Weight gain, drowsiness, constipation, fear of cold, rough and dry skin | Height: 140 cm (the average height of parents is 158 cm), Bone age delay of 2 years, Adolescent, The pubertal state is B2A1P2 (stage TannerII) | Imaging showed: sellar mass, size of (6 × 17 × 9 mm), considered for non‐function pituitary tumor | FT4↓, TSH↑, TMAb+ | Oral levothyroxine | After 6 months, the pituitary size returned to normal; FT4 and TSH returned to normal |
3 | Bhansali, 2004 5 | 13 | Male | Weight gain, drowsiness, fatigue, snoring, constipation, hoarseness | Height: 145 cm (the average height of parents is 168 cm), Bone age is normal, The pubertal status is A1P2 The bilateral testicular volume is 4 mL | MRI: significant pituitary enlargement, Size is (14.1 × 18.5 × 10.1 mm), extending to the saddle | FT4↓, TSH↑, TMAb+, FSH↓, LH↓, COR (8 AM)↓ | Oral levothyroxine | After 6 months, the pituitary size returned to normal; FT4 and TSH returned to normal |
4 | Ashley, 2005 21 | 12 | Female | Headache, fatigue | Height ominous, No secondary sexual characteristics | MRI: (1) showing uniform enhancement of the saddle mass, extending to the saddle, pressing the optic cross, and showing a pointed upper edge (2) There was no expansion or erosion of the butterfly saddle (3) Did not see saddle side involvement | FT4↓, TSH↑, PRL↑ | Oral levothyroxine | After 1 month, the pituitary size returned to normal; clinical symptoms resolved |
5 | Jia, 2007 9 | 16 | Female | Weight gain, dizziness, slow mobility, hypomnesis, sluggish responses, constipation, rough skin | Height: 155 cm; Menstruation regularity, menstrual period is extended for a few days than before; No pubic hair, axillary hair | MRI: the butterfly saddle was small, the pituitary volume increased but symmetrical, the height was about 14 mm, and the pituitary stalk was centered Others: B‐ultrasound suggests a small amount of pericardial effusion | FT4↓, TSH↑, TGAb+, TMAb+, TRAb‐, TSI−, PRL↑, TC↑, TG↑, LDL‐C↑ | Oral levothyroxine | After 3 months, the pituitary size returned to normal; FT4, TSH and PRL returned to normal; and the clinical symptoms were significantly relieved |
6 | Lee, 2008 16 | 10.3 | Female | Bitemporal hemianopsia | Height: 121 cm, Bone age was 7 years and 10 months, Bilateral breast enlargement (15 cm × 15 cm, stage Tanner II), pubic hair (stage Tanner I), and no precocious puberty appeared in the external genitals, The sign of the uterus was (2.62 × 0.96) cm | MRI revealed a mass in the (3.8 × 9.6 × 12.1 mm) | FT4↓, TSH↑, TPOAb−, TGAb− | Oral levothyroxine | After 2 months, FT4 and TSH returned to normal;The growth rate was increased to 0.8 cm/month, Bilateral breast enlargement (25 cm × 25 cm, Tanner II), pubic hair (Tanner I); After 6 months, the pituitary size was normalized and the growth rate was normalized |
7 | Simsek, 2009 7 | 14.5 | Male | Pale and swollen face, mild headaches, fatigue, fear of cold, chronic constipation | Short stature (height: 135 cm), Adolescence was delayed, No secondary sexual signs appeared | MRI: the pituitary mass was large and homogeneous, and pituitary adenoma was considered | FT4↓, TSH↑, PRL, GH, FSH, and LH deficiency | Oral levothyroxine | After 6 months, pituitary enlargement disappeared; After 3 years, clinical symptoms disappeared; FT4, TSH and PRL normalized |
8 | Simsek, 2009 7 | 13 | Female | Excessive menstruation, fear of cold, fatigue | Short stature (height: 146 cm), Breast (Tanner IV phase), Pubis (Tanner III phase) | MRI: enlarged pituitary enlargement (11 mm) to the saddle on the extension | FT4↓, TSH↑, TPOAb+, PRL↑, GH↓ | Oral levothyroxine | After 3 years, pituitary enlargement disappeared; menstruation to normal, clinical symptoms disappeared; FT4, TSH and PRL returned to normal |
9 | Babu, 2010 19 | 15 | Female | Headaches, weight gain, blurred vision, dry and rough skin, mild hirsutism | Height ominous, Menstrual disorder | MRI:a mass in the sellar region, extending to the saddle, with uniform enhancement, suggesting a pituitary large adenoma Others: Visual field tests suggest a mildly reversible anterior visual access pathway oppress | FT4↓, TSH↑, TPOAb+, PRL↑ | Oral levothyroxine | After 3 weeks, the PRL returned to normal; After 3 months, the pituitary size returned to normal; FT4 and TSH returned to normal and clinical symptoms were significantly relieved; the visual field and eye movements were normal |
10 | Wang, 2010 17 | 13 | Female | growth retardation, fear of cold | Height: 129 cm; Prepubertal state | MRI: saddle area occupancy, T 1 WI and Other signals, T 2 WI slightly higher signal, pituitary uniform strengthening | FT4↓, TSH↑, TGAb+, PRL↑, FSH↓ | Oral levothyroxine | After 6 months, the pituitary size returned to normal; FT4, TSH and PRL normalized; height increased by 5 cm |
11 | Cekmez, 2011 10 | 12 | Female | growth retardation, dry hair | Height: 129.4 cm; Bone age delay of 4 years; Prepubertal state | MRI: an anterior pituitary mass of size (16 × 12 mm) with the lesion slightly extending to the right supraselllar pool | FT4↓, TSH↑, TPOAb‐, PRL, GH, LH and FSH were lower | Oral levothyroxine | After 3 months, the pituitary mass was significantly reduced;FT4 and TSH returned to normal |
12 | Shen, 2013 22 | 12 | Male | fatigue, anorexia, asthma after activity, yellow skin, intermittent eyelid edema | Height ominous | MRI shows: pituitary abnormal strengthening nodule, size is (1.7 × 1.6 × 1.6 cm) Other: CT suggested pericardial effusion and bilateral pleural effusion | FT4↓, TSH↑, TPOAb+, TGAb+, PRL↑ | Oral levothyroxine | After 2 months, the pituitary mass shrank significantly, FT4 and TSH returned to normal, and the clinical symptoms disappeared; After 3 months, the size and shape of the pituitary gland returned to normal; One year later, the height increased by 8 cm higher than before |
13 | Cebeci, 2013 11 | 12 | Male | Headache, blurred vision, bloating, fatigue, Hoffman syndrome, pale face, dry skin, bilateral pseudoenlarged shoulder and calf muscles, proximal muscle weakness | Height: 140 cm, Bone age delay of 2 years, Pubertal status (stage Tanner III) | MRI: the pituitary gland was enlarged, 12 mm, extending to the suprasellar pool, and had no obvious compression It is even enhanced Other: ophthalmological examination suggested bilateral optic papilledema | FT4↓, TSH↑, anti‐thyroid antibody+ | Oral levothyroxine and acetazolamide | After 3 months, the clinical symptoms had disappeared; After 6 months, the pituitary size (5 mm) was normalized, the growth rate was 6 cm/year, and the CPK levels were decreased |
14 | Sterkenburg, 2014 14 | 13 | Female | Headache, fatigue | Short stature (Height ominous) | MRI: a homogeneous mass in the selellar pituitary, enlarging upward and almost reaching the optic chiasm | FT4↓, TSH↑, TPOAb+, LH and FSH were at the prepubertal level | Oral levothyroxine | After 3 months, the pituitary size returned to normal |
15 | Zhang, 2017 12 | 14 | Male | Gain weight, growth retardation, constipation, muscle weakness, poor academic performance, and VWG syndrome | Height: 139 cm, Bone age delay of 4 years, Pseudoprecocious puberty, with a bilateral testicular volume of 25 mL and a stretched penile length of 5 cm, with no pubic hair or armpit hair | MRI: pituitary enlargement, and pituitary hyperplasia was considered Other: B‐ultrasound suggested hepatomegaly | FT4↓, TSH↑, TPOAb+, TGAb+, PRL↑, LH↓, T↓, TC↑, AST↑, ALT↑, HGB↓ | Oral levothyroxine | After 6 months, the pituitary mass was significantly reduced;FT4 and TSH returned to normal; height increased by 5 cm |
16 | Bhattacharya, 2020 6 | 11 | Female | Drowsiness, poor learning, fear of cold, weight gain, full moon face, hoarseness | Height: 128 cm, Menstrual rule | MRI: a sellar mass, the size of (1.58 × 1.43 × 3.11 cm), a small area of necrosis, and contrast enhancement | T4↓, TSH↑, TPOAb+, PRL↑ | Oral levothyroxine | After 2 months, T4 was normal; After 6 months, the pituitary size returned to normal; TSH and PRL returned to normal |
17 | Yu, 2020 13 | 15 | Male | Obesity, poor appetite, hypomnesis, insomnia | Short stature (height: 148 cm), The penis does not grow (the stretched penis is 25 cm in length), No pubic hair in the external genital organs (stage Tanner I), The left testicular volume is 10 mL and right testicular volume is 9 mL | MRI: pituitary fossa mass, T1 signal in sella, T2 signal is slightly longer, uneven and slightly strengthened; the pituitary stalk is not clear and the optic cross moves up | FT4↓, TSH↑, TPOAb+, TGAb+, FSH↓, LH↓, T↓, IGF−1↓, PRL↑ | Oral levothyroxine | After 6 months, the clinical symptoms were significantly relieved, the pituitary gland was significantly decreased, and the levels of FT4, TSH, FSH, LH, T, and IGF‐1 returned to normal; After 16 months, the height increased to 161 cm, and the penis grew (the extended penis was 7 cm long), Pubic hair begins to grow on the external genitalia (Tanner IV Phase 1);The volume of the bilateral testis was 15 mL |
18 | Barbero, 2022 8 | 13 | Female | Hypermenorrhea, xerosis cutis, acanthosis nigricans, thin hair | Height: 133.8 cm (average height of parents: 155 cm), Bone age was 96 years old, Menarche, 17 years ago | MRI: the gland in contact with the optic cross was enlarged with a height of 16 mm Other: B ultrasound indicates that the size of the right ovarian cyst is (40 × 28 mm) | FT4↓, TSH↑, TPOAb+, TGAb+, GH↓, HGB↓, APTT↑, FIB↓, vWF ↓ | Oral levothyroxine | After 1 month, FT4, APTT, FIB, and vWF returned to normal; TSH returned to normal after 7 weeks; The pituitary size was normalized after 3 months |
19 | Ms, 2022 18 | 17 | Female | Headache, bitemporal hemianopia, fatigue, face swelling, weight gain, dry and rough skin, hoarseness, alopecia, mucinous oedema | Height ominous, Menstrual disorder | MRI: a diffuse enhancing lesion in the sellar region extending into the optic chiasm | FT4↓, TSH↑, TPOAb +, PRL, Morning COR↓ | Oral levothyroxine and hydrocortisone | After 7 months, the pituitary mass was significantly reduced; regular menstruation, normal vision, and clinical symptoms were significantly relieved |
20 | Wang, 2022 20 | 17 | Female | Headache, anemia, pale face, swollen face | Height ominous, menstrual unknown | MRI: the soft tissue mass was seen in the saddle, the size of (0.8 × 1.8 × 1.4 cm) was significantly strengthened, the upward growth of the saddle diaphragm, the pituitary stalk was shortened and centered, no obvious subsidence at the bottom of the saddle, and the mass compressed the optic cross | FT4↓, TSH↑, TPOAb+, TGAb+, PRL↑ | Oral levothyroxine | After 9 months, FT4 returned to normal and TSH decreased significantly; clinical symptoms resolved significantly After 2 years, the pituitary size returned to normal |
Abbreviations: ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate transaminase; COR, cortisol; FIB, fibrinogen; FSH, follicle stimulating hormone; FT4, free thyroxine; GH, growth hormone; HGB, hemoglobin; LDL‐C, low‐density lipoprotein cholesterol; LH, luteinizing hormone, PRL, prolactin; T, testosterone; TC, total cholesterol; TG, triglyceride; TGAb, thyroglobulin antibody; TMAb, thyroid microsomal antibodies; TPOAb, thyroid peroxide antibody; TRAb, thyrotropin receptor antibody; TSH, thyroid‐stimulating hormone; TSI, thyroid stimulating immunoglobulin; VWF, von Willebrand factor.